How the Australia-US free trade agreement compromised the pharmaceutical benefits scheme

Simple item page
dc.contributor.authorFaunce, Thomasen_AU
dc.date.accessioned2015-12-10T22:15:03Z
dc.date.issued2015
dc.date.updated2015-12-09T08:12:37Z
dc.identifier.issn1035-7718
dc.identifier.urihttp://hdl.handle.net/1885/50444
dc.publisherCarfax Publishing, Taylor & Francis Group
dc.sourceAustralian Journal of International Affairs
dc.titleHow the Australia-US free trade agreement compromised the pharmaceutical benefits scheme
dc.typeJournal article
local.bibliographicCitation.issue2015
local.bibliographicCitation.startpage6
local.contributor.affiliationFaunce, Thomas, ANU College of Law, ANU
local.contributor.authoremailu9705219@anu.edu.au
local.contributor.authoruidFaunce, Thomas, u9705219
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor180199 - Law not elsewhere classified
local.identifier.absseo929999 - Health not elsewhere classified
local.identifier.ariespublicationu1000239xPUB204
local.identifier.citationvolumeOnline
local.identifier.doi10.1080/10357718.2015.1048785
local.identifier.scopusID2-s2.0-84941738519
local.identifier.uidSubmittedByu1000239
local.type.statusPublished Version

Downloads

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
01_Faunce_How_the_Australia-US_free_2015.pdf
Size:
70.23 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2024 LYRASIS